Abstract:Abstract Background/Objective: Tanshinone IIA, which is mainly used for the treatment of cardiovascular diseases, has been shown to inhibit the progression of a variety of cancers in recent years. In this study, we showed that tanshinone IIA could inhibit the proliferation of triple-negative breast cancer cells and promote their apoptosis. However, the specific mechanisms were not clear. Our research aims to clarify its mechanism. Method: At the first, the effects of tanshinone IIA on cell viability of triple-negative breast cancer cell lines were analyzed. Then a mouse transplanted tumor model was used to study the anti-cancer effect in vivo. The related targets and mechanisms of tanshinone IIA were predicted through network-based systems biology and molecular docking analysis. At last, molecular docking and the molecular biological techniques were used to evaluate the predicted target. Results: Tanshinone IIA could inhibit the cell proliferation after incubation for 24 h. At a concentration of 50 µM, Tanshinone IIA could half-inhibit the proliferation of 4T1 cells. Consistent with the results of the cell viability assays, Tan IIA induced the cancer cell apoptosis and resulted in a significant reduction in tumor volume. Then we analyzed the possible mechanisms with network-based systems biology, and predicted TP53, NF-κB, AKT, MYC and BCL-2 were the hub targets of Tan IIA for triple-negative breast cancer. P53 signaling pathway, PI3K/Akt pathway, the MAPK signaling pathway and the mTOR signaling pathways were the possible involved mechanisms. Using molecular docking analysis, we found Tan IIA has a high affinity for p53, Bcl-2 and NF-κB1, the binding energy were − 6.92, -6.07 and − 6.28 kcal/mol, respectively. Through western blotting assays, we further found the p53 protein expression was increased while Bcl-2 protein was decreased after Tan IIA treatment. These results verified that Tan IIA promotes apoptosis by down-regulating BCL2 and up-regulating TP53 in triple-negative breast cancer.Conclusion: Our findings revealed the mechanism of Tan IIA in promoting apoptosis and inhibiting proliferation in triple-negative breast cancer cells, which provides a theoretical and experimental basis for further research into the anticancer effects of Tan IIA.

[Anticancer Effect of Tanshinone and Its Mechanisms].

[A Study on Anticancer Activity of Tanshinone II A Against Human Breast Cancer].

[A Study on the Effect of Tanshinone II A Against Human Breast Cancer in Vivo].

Potential Anticancer Activity of Tanshinone IIA Against Human Breast Cancer

Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.

The mechanisms of tanshinone in the treatment of tumors

The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients

Cytotoxic Effect and Apoptotic Mechanism of Tanshinone A, a Novel Tanshinone Derivative, on Human Erythroleukemic K562 Cells.

Tanshinone IIA: A Review of its Anticancer Effects

Effects and Mechanism of Tanshinone II A in Proliferation, Apoptosis, and Migration of Human Colon Cancer Cells.

Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis

Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis

An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)

Anticancer potential of Salvia miltiorrhiza and its tanshinones: an efficacy perspective

The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line

The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors

Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer.

Tanshinone IIA Promotes Apoptosis by Down-Regulating BCL2 and Up-Regulating TP53 in Triple-Negative Breast Cancer

Anti-proliferative Effect of TanshinoneⅡA on Cervical Squamous Cancer Cells and Its Estrogen Receptor Subtype Mediated Mechanism

Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer

Tanshinone IIA Inhibits Angiogenesis through Down Regulation of COX-2 in Human Colorectal Cancer